Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-19

Clinical Trial Update: The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating microneedle-assisted botulinum toxin delivery for palmar hyperhidrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: University of California, Davis | Conditions: Hyperhidrosis | Phase 1 | Status: COMPLETED